The Phencyclidine/N-Methyl-D-Aspartate (PCP/ NMDA) Model of Schizophrenia: Theoretical and Clinical Implications
Uriel Heresco-Levy, Daniel C Javitt, Stephen R Zukin
Psychiatric Annals March 1, 1993 DOI: 10.3928/0048-5713-19930301-09 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|
Abstract
The hyperdopaminergic theory of schizophrenia cannot account for many dimensions of the illness.
Citations in the library
Cites 5
- Recent advances in the phencyclidine model of schizophrenia American Journal of Psychiatry October 1, 1991
- Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. Simulation of schizophrenic performance with phencyclidine hydrochloride (Sernyl), lysergic acid diethylamide (LSD-25), and amobarbital (Amytal) sodium; II. Symbolic and sequential thinking. Archives of General Psychiatry May 1, 1962
- Specific binding of [3H]phencyclidine in rat central nervous tissue: further characterization and technical considerations. Brain Research January 10, 1983
- Acute phencyclidine intoxication: clinical patterns, complications, and treatment. Annals of emergency medicine June 1981
- Phencyclidine-induced psychosis. American Journal of Psychiatry September 1978